STAT+: Biotech startup raises $175 million to advance Alzheimer’s antibody therapy
STAT [Unofficial]
February 18, 2026
Is there room for more Alzheimer’s antibody therapies on the market? Korsana Biosciences' investors think so.
Discussion in the ATmosphere